An angel investor based in London, England, United Kingdom, Paolo Malerba has one known investment, HUMA.
Is Paolo Malerba a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Paolo Malerba portfolio company (1)
- HUMA
Affiliated funds' portfolios
Strategy Lead at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Clinical Trials, Drug Discovery and Gene Therapy will recognize the pattern in this portfolio.
The portfolio and focus above give founders context on whether Paolo Malerba matches their raise.
Colleagues at Novartis
Similar investors
Showing 20 of 100
Frequently asked questions
Who is Paolo Malerba?
Paolo Malerba is an angel investor based in London, England, United Kingdom with one known investment on file, HUMA. The sections above list the sectors and firms attached to that record.
What does Paolo Malerba invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Clinical Trials, Drug Discovery and Gene Therapy. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
Which firm is Paolo Malerba listed at?
Paolo Malerba is listed as Strategy Lead at Novartis. 11 other people in the database share a firm with Paolo Malerba.
How do I contact Paolo Malerba?
An email address, a phone number and a LinkedIn page are on file for Paolo Malerba. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal
